Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-26 @ 12:51 AM
NCT ID: NCT00957034
Description: None
Frequency Threshold: 0
Time Frame: Six-month treatment period.
Study: NCT00957034
Study Brief: Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
450 µg/Day Testosterone 450 micrograms/day transdermal testosterone patch None None 2 7 4 7 View
Placebo placebo patch None None 2 6 4 6 View
300 µg/Day Testosterone 300 micrograms/day transdermal testosterone patch None None 0 4 2 4 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cardiac Failure Congestive SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (13.0) View
Chronic Obstructive Pulmonary Disease SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (13.0) View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Gastroenteritis Viral SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Application Site Reaction SYSTEMATIC_ASSESSMENT General disorders MedDRA (13.0) View
Oedema Peripheral SYSTEMATIC_ASSESSMENT General disorders MedDRA (13.0) View
Rhinitis Allergic SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (13.0) View
Asthma SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (13.0) View
Sinus Congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (13.0) View
Cardiac Failure Congestive SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (13.0) View
Myocardial Infarction SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (13.0) View
Hyperparathyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA (13.0) View
Abdominal Pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (13.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (13.0) View
Fungal Skin Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Urinary Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Viral Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Tendon Injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (13.0) View
Contusion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (13.0) View
Gout SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (13.0) View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (13.0) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (13.0) View
Renal Failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (13.0) View
Breast Mass SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (13.0) View
Hirsutism SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (13.0) View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (13.0) View